$SERV
Serve Robotics Inc. /DE/

2023 Q2 Form 10-Q Financial Statement

#000121390023039642 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue
YoY Change
Cost Of Revenue $758.6K $367.3K
YoY Change
Gross Profit -$656.4K -$327.0K
YoY Change
Gross Profit Margin
Selling, General & Admin $3.464M $291.1K
YoY Change
% of Gross Profit
Research & Development $4.209M $2.083M
YoY Change
% of Gross Profit
Depreciation & Amortization $931.3K $465.6K
YoY Change
% of Gross Profit
Operating Expenses $7.672M $3.900M
YoY Change
Operating Profit -$17.84K -$11.48K -$7.888K
YoY Change -7.04% 45.56%
Interest Expense -$1.776M $41.74K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$864.6K -$910.9K
YoY Change
Pretax Income -$10.10M
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$17.84K -$11.48K -$7.888K
YoY Change -7.04% 45.56% -51.36%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 5.000M shares 5.000M shares 5.000M shares
Diluted Shares Outstanding 5.000M shares 5.000M shares 5.000M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.91K
YoY Change
Cash & Equivalents $9.236K $12.37K $863.00
Short-Term Investments
Other Short-Term Assets $417.7K
YoY Change
Inventory $623.0K
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $9.236K $12.37K
YoY Change 245.53%
LONG-TERM ASSETS
Property, Plant & Equipment $3.449M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $512.7K
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $9.236K $12.37K
Total Long-Term Assets $0.00 $0.00
Total Assets $9.236K $12.37K
YoY Change 245.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.60K $15.89K
YoY Change 6.0%
Accrued Expenses $620.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.991M
YoY Change
Long-Term Debt Due $3.271M
YoY Change
Total Short-Term Liabilities $162.1K $147.4K
YoY Change 59.02%
LONG-TERM LIABILITIES
Long-Term Debt $1.411M
YoY Change
Other Long-Term Liabilities $17.61M
YoY Change
Total Long-Term Liabilities $19.02M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $162.1K $147.4K
Total Long-Term Liabilities $19.02M
Total Liabilities $162.1K $147.4K
YoY Change 59.02%
SHAREHOLDERS EQUITY
Retained Earnings -$153.4K -$135.5K
YoY Change 53.72%
Common Stock $500.00 $500.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$152.9K -$135.0K -$80.08K
YoY Change
Total Liabilities & Shareholders Equity $9.236K $12.37K
YoY Change 245.53%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$17.84K -$11.48K -$7.888K
YoY Change -7.04% 45.56% -51.36%
Depreciation, Depletion And Amortization $931.3K $465.6K
YoY Change
Cash From Operating Activities -$6.590M -$5.591K -$9.388K
YoY Change -40.45%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.893M $17.50K $9.980K
YoY Change 75.35%
NET CHANGE
Cash From Operating Activities -6.590M -$5.591K -$9.388K
Cash From Investing Activities 0.000
Cash From Financing Activities 3.893M $17.50K $9.980K
Net Change In Cash -2.697M $11.91K $592.00
YoY Change 1911.66%
FREE CASH FLOW
Cash From Operating Activities -$6.590M -$5.591K -$9.388K
Capital Expenditures $0.00
Free Cash Flow -$6.590M -$5.591K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q1 us-gaap Revenues
Revenues
usd
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q1 us-gaap Revenues
Revenues
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5000000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10000 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
131500 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
114000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
147391 usd
CY2023Q1 us-gaap Cash
Cash
12366 usd
CY2022Q4 us-gaap Cash
Cash
457 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
12366 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
457 usd
CY2023Q1 us-gaap Assets
Assets
12366 usd
CY2022Q4 us-gaap Assets
Assets
457 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15891 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-56237
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Patricia Acquisition Corp.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3844872
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2255 Glades Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 324A
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33431
CY2023Q1 dei City Area Code
CityAreaCode
(561)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
989-2208
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5000000 shares
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
124000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
147391 usd
CY2022Q4 us-gaap Liabilities
Liabilities
124000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
500 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
500 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-135525 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124043 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-135025 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-123543 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12366 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
457 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11482 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7888 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11482 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7888 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11482 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7888 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5000000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-72189 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7888 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-80077 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-123543 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11482 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-135025 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11482 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7888 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5891 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1500 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5591 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9388 usd
CY2023Q1 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
17500 usd
CY2022Q1 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
9980 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17500 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9980 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
11909 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
592 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
457 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
271 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12366 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
863 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1. <span style="text-decoration:underline">Nature of Operations</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Patricia Acquisition Corp. (the “Company”) was incorporated in the State of Delaware on November 9, 2020. The Company’s management has chosen December 31st for its fiscal year end.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly traded corporation. The Company’s principal business objective is to achieve long-term growth potential through a combination with a business, rather than immediate short-term earnings. The Company will not restrict its potential target companies to any specific business, industry, or geographical location. The analysis of business opportunities will be undertaken by, or under the supervision of, the officer and directors of the Company.</p>
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p>
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5000000 shares
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
24700 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
22300 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
117500 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
106000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.32 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21 pure
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.11 pure
CY2023Q1 us-gaap Derivative Variable Interest Rate
DerivativeVariableInterestRate
0.18 pure
CY2023Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
131500 usd
CY2022 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
114000 usd
CY2023Q1 patr Going Concern
GoingConcern
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 6. <span style="text-decoration:underline">Going Concern</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has accumulated deficit and total stockholders' deficit of $135,525 and $135,025, respectively, as of March 31, 2023. Management believes these conditions raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the date these financial statements are issued. Management intends to finance operations over the next twelve months through additional borrowings on the existing Note.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.</p>
CY2023Q1 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
135525 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
135025 usd
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001832483

Files In Submission

Name View Source Status
0001213900-23-039642-index-headers.html Edgar Link pending
0001213900-23-039642-index.html Edgar Link pending
0001213900-23-039642.txt Edgar Link pending
0001213900-23-039642-xbrl.zip Edgar Link pending
f10q0323ex31-1_patriciaacq.htm Edgar Link pending
f10q0323ex32-1_patriciaacq.htm Edgar Link pending
f10q0323_patriciaacq.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
patr-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
f10q0323_patriciaacq_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
patr-20230331_cal.xml Edgar Link unprocessable
patr-20230331_def.xml Edgar Link unprocessable
patr-20230331_lab.xml Edgar Link unprocessable
patr-20230331_pre.xml Edgar Link unprocessable